{"title":"皮质多发性硬化病理实验模型","authors":"Maarten E. Witte, Jack van Horssen","doi":"10.1016/j.ddmod.2018.09.002","DOIUrl":null,"url":null,"abstract":"<div><p><span>Grey matter tissue damage is a characteristic pathological hallmark of multiple sclerosis. Although evidence is emerging that cortical atrophy is strongly associated with sustained </span>disease progression<span><span><span>, the underlying pathological processes that contribute to neurodegeneration remain poorly understood. One reason for this is that key features of progressive MS, such as cortical </span>demyelination, microglial </span>cell activation<span><span> and neurodegeneration are absent in most of the commonly used rodent MS models. In this short review we will provide an overview of experimental MS animal models that exhibit MS-like cortical pathology. These models will be instrumental in unravelling the pathogenic mechanisms that contribute to cortical pathology and testing the efficacy of </span>neuroprotective therapies for progressive MS patients.</span></span></p></div>","PeriodicalId":39774,"journal":{"name":"Drug Discovery Today: Disease Models","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ddmod.2018.09.002","citationCount":"0","resultStr":"{\"title\":\"Experimental models of cortical multiple sclerosis pathology\",\"authors\":\"Maarten E. Witte, Jack van Horssen\",\"doi\":\"10.1016/j.ddmod.2018.09.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>Grey matter tissue damage is a characteristic pathological hallmark of multiple sclerosis. Although evidence is emerging that cortical atrophy is strongly associated with sustained </span>disease progression<span><span><span>, the underlying pathological processes that contribute to neurodegeneration remain poorly understood. One reason for this is that key features of progressive MS, such as cortical </span>demyelination, microglial </span>cell activation<span><span> and neurodegeneration are absent in most of the commonly used rodent MS models. In this short review we will provide an overview of experimental MS animal models that exhibit MS-like cortical pathology. These models will be instrumental in unravelling the pathogenic mechanisms that contribute to cortical pathology and testing the efficacy of </span>neuroprotective therapies for progressive MS patients.</span></span></p></div>\",\"PeriodicalId\":39774,\"journal\":{\"name\":\"Drug Discovery Today: Disease Models\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.ddmod.2018.09.002\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Discovery Today: Disease Models\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1740675718300124\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today: Disease Models","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1740675718300124","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
Experimental models of cortical multiple sclerosis pathology
Grey matter tissue damage is a characteristic pathological hallmark of multiple sclerosis. Although evidence is emerging that cortical atrophy is strongly associated with sustained disease progression, the underlying pathological processes that contribute to neurodegeneration remain poorly understood. One reason for this is that key features of progressive MS, such as cortical demyelination, microglial cell activation and neurodegeneration are absent in most of the commonly used rodent MS models. In this short review we will provide an overview of experimental MS animal models that exhibit MS-like cortical pathology. These models will be instrumental in unravelling the pathogenic mechanisms that contribute to cortical pathology and testing the efficacy of neuroprotective therapies for progressive MS patients.
期刊介绍:
Drug Discovery Today: Disease Models discusses the non-human experimental models through which inference is drawn regarding the molecular aetiology and pathogenesis of human disease. It provides critical analysis and evaluation of which models can genuinely inform the research community about the direct process of human disease, those which may have value in basic toxicology, and those which are simply designed for effective expression and raw characterisation.